Search the collection

5 results for Borzilleri,+Robert

Sort by:

Sort by

Limit results to:

20 per page

5 results for Borzilleri,+Robert

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
Newsletter articlesFull Text
Borzilleri Robert M, Cai Zhen-Wei, Tebben Andrew J, Perez Heidi L, Zhang Liping, Schroeder Gretchen M, Wei Donna D and Bristol-Myers Squibb Company Submit Patent Application for Substituted Sulfonamid...
Publisher:New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title:Global IP News. Pharmaceutical Patent News, 2014
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Preclinical discovery of ixabepilone, a highly active antineoplastic agent
Author / Creator:Lee, Francis Y. F. ; Borzilleri, Robert ; Fairchild, Craig R. ; Kamath, Amrita ; Smykla, Richard ; Kramer, Robert ; Vite, Gregory
Publisher:Berlin/Heidelberg: Springer-Verlag
Journal title:Cancer chemotherapy and pharmacology, 2008-12, Vol.63 (1), p.157-166
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
Author / Creator:Nelp, Micah T. ; Kates, Patrick A. ; Hunt, John T. ; Newitt, John A. ; Balog, Aaron ; Maley, Derrick ; Zhu, Xiao ; Abell, Lynn ; Allentoff, Alban ; Borzilleri, Robert ; Lewis, Hal A. ; Lin, Zeyu ; Seitz, Steven P. ; Yan, Chunhong ; Groves, John T.
Publisher:United States: National Academy of Sciences
Journal title:Proceedings of the National Academy of Sciences - PNAS, 2018-03, Vol.115 (13), p.3249-3254
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
Newsletter articlesFull Text
Ensemble Therapeutics Corporation; Patent Issued for Macrocyclic Compounds for Inhibition of Inhibitors of Apoptosis (USPTO 9605022)
Publisher:Atlanta: NewsRx
Journal title:Cancer Gene Therapy Week, 2017, p.320
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
Newsletter articlesFull Text
Pharmaceutical Companies; Patent Issued for 4-Pyridinone Compounds and Their Use for Cancer
Publisher:Atlanta: NewsRx
Journal title:Biotech Week, 2012, p.303
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Borzilleri Robert M, Cai Zhen-Wei, Tebben Andrew J, Perez Heidi L, Zhang Liping, Schroeder Gretchen M, Wei Donna D and Bristol-Myers Squibb Company Submit Patent Application for Substituted Sulfonamid...

Export this record

Export record to excel

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

Export this record

Export record to excel

Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form

Export this record

Export record to excel

Ensemble Therapeutics Corporation; Patent Issued for Macrocyclic Compounds for Inhibition of Inhibitors of Apoptosis (USPTO 9605022)

Export this record

Export record to excel

Pharmaceutical Companies; Patent Issued for 4-Pyridinone Compounds and Their Use for Cancer

Refine your search